← Back to Clinical Trials
Recruiting NCT03574103

NCT03574103 Chronic Effect of Fasting

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03574103
Status Recruiting
Phase
Sponsor Federal University of Minas Gerais
Condition Overweight and Obesity
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2018-07-09
Primary Completion 2025-09

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 59 Years
Study Type INTERVENTIONAL
Interventions
Caloric restriction onlyCaloric restriction plus TRF morningCaloric restriction plus TRF night

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2018-07-09 with a primary completion date of 2025-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study is to determine if time-restricted feeding (TRF) is an effective dietary strategy to weight loss after 8 weeks intervention. TRF will be compared with an intervention without restriction in time for feeding. Both strategies will be with caloric restriction.

Eligibility Criteria

Inclusion Criteria: * Females; * Aged between 18 and 59 years old; * Body mass index equal or greater 25 kg/m²; * Agree to sign the informed consent. Exclusion Criteria: * Any chronic health conditions (e.g. chronic renal failure, autoimmune, heart, and liver disease); * Thyroid diseases or medications for its treatment; * Medications known to affect total energy expenditure; * Use of steroids, immunosuppressants or non-steroidal anti-inflammatory drugs, weight-loss medications, oral hypoglycemic agents or insulin and any medications that influence metabolic and/or inflammatory parameters; * Previous surgery for weight loss; * Pregnancy or breast-feeding; * Smoking; * Alcohol use (\>2 doses/day).

Contact & Investigator

Central Contact

Adaliene VM Ferreira, PhD

✉ adaliene@gmail.com

📞 +553134093680

Frequently Asked Questions

Who can join the NCT03574103 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 59 Years, studying Overweight and Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03574103 currently recruiting?

Yes, NCT03574103 is actively recruiting participants. Contact the research team at adaliene@gmail.com for enrollment information.

Where is the NCT03574103 trial being conducted?

This trial is being conducted at Belo Horizonte, Brazil, Belo Horizonte, Brazil.

Who is sponsoring the NCT03574103 clinical trial?

NCT03574103 is sponsored by Federal University of Minas Gerais. The trial plans to enroll 45 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology